Describe the latest evolution of SARS-CoV-2 variants and new viral mutants and the COVID-19 pandemic and how this potentially impacts therapeutic and vaccine development efforts.
Review the most recent data available from the development program and real-world data of the Pfizer-BioNTech COVID-19 vaccine.
Summarize the development program and latest data available for Pfizer’s oral protease inhibitor, nirmatrelvir.